tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Connect Biopharma reports Q3 EPS (31c), consensus (24c)
PremiumThe FlyConnect Biopharma reports Q3 EPS (31c), consensus (24c)
1M ago
Promising Outlook for Connect Biopharma Holdings: Rademikibart’s Potential in Asthma and COPD
Premium
Ratings
Promising Outlook for Connect Biopharma Holdings: Rademikibart’s Potential in Asthma and COPD
2M ago
Connect Biopharma initiated with a Buy at BTIG
Premium
The Fly
Connect Biopharma initiated with a Buy at BTIG
2M ago
Connect Biopharma completes termination of ADR program, lists on Nasdaq
PremiumThe FlyConnect Biopharma completes termination of ADR program, lists on Nasdaq
4M ago
Connect Biopharma Advances Clinical Trials and Nasdaq Listing
Premium
Company Announcements
Connect Biopharma Advances Clinical Trials and Nasdaq Listing
4M ago
Connect Biopharma patners with Ickey Woods, Jovante Woods Foundation
Premium
The Fly
Connect Biopharma patners with Ickey Woods, Jovante Woods Foundation
4M ago
Connect Biopharma announces expansion of board, appoints Schoeneck as director
PremiumThe FlyConnect Biopharma announces expansion of board, appoints Schoeneck as director
5M ago
Northland starts Connect Biopharma at Outperform on chance to define new class
Premium
The Fly
Northland starts Connect Biopharma at Outperform on chance to define new class
5M ago
Connect Biopharma initiated with an Outperform at Northland
Premium
The Fly
Connect Biopharma initiated with an Outperform at Northland
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100